Pulmonary/ Respiratory Drug Delivery Market, Global Outlook and Forecast 2022-2028

February 2022 | 67 pages | ID: PB8C8C055104EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pulmonary/ Respiratory Drug Delivery in Global, including the following market information:

Global Pulmonary/ Respiratory Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pulmonary/ Respiratory Drug Delivery market was valued at 32470 million in 2021 and is projected to reach US$ 41390 million by 2028, at a CAGR of 3.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Suspension Aerosol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pulmonary/ Respiratory Drug Delivery include Merck, Teva Pharmaceutical, 3M, Astrazeneca, Boehringer Ingelheim, Cipla, Glaxosmithkline, Novartis and Omron Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary/ Respiratory Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pulmonary/ Respiratory Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pulmonary/ Respiratory Drug Delivery Market Segment Percentages, by Type, 2021 (%)

• Suspension Aerosol
• Solution Aerosol
• Dry Powder Formulation

Global Pulmonary/ Respiratory Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pulmonary/ Respiratory Drug Delivery Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Home Care

Global Pulmonary/ Respiratory Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pulmonary/ Respiratory Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pulmonary/ Respiratory Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pulmonary/ Respiratory Drug Delivery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Teva Pharmaceutical
• 3M
• Astrazeneca
• Boehringer Ingelheim
• Cipla
• Glaxosmithkline
• Novartis
• Omron Corporation
• Sunovion Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pulmonary/ Respiratory Drug Delivery Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pulmonary/ Respiratory Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PULMONARY/ RESPIRATORY DRUG DELIVERY OVERALL MARKET SIZE

2.1 Global Pulmonary/ Respiratory Drug Delivery Market Size: 2021 VS 2028
2.2 Global Pulmonary/ Respiratory Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pulmonary/ Respiratory Drug Delivery Players in Global Market
3.2 Top Global Pulmonary/ Respiratory Drug Delivery Companies Ranked by Revenue
3.3 Global Pulmonary/ Respiratory Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Pulmonary/ Respiratory Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pulmonary/ Respiratory Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pulmonary/ Respiratory Drug Delivery Players in Global Market
  3.6.1 List of Global Tier 1 Pulmonary/ Respiratory Drug Delivery Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pulmonary/ Respiratory Drug Delivery Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pulmonary/ Respiratory Drug Delivery Market Size Markets, 2021 & 2028
  4.1.2 Suspension Aerosol
  4.1.3 Solution Aerosol
  4.1.4 Dry Powder Formulation
4.2 By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue & Forecasts
  4.2.1 By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2022
  4.2.2 By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2023-2028
  4.2.3 By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pulmonary/ Respiratory Drug Delivery Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Home Care
5.2 By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue & Forecasts
  5.2.1 By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2022
  5.2.2 By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2023-2028
  5.2.3 By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pulmonary/ Respiratory Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue & Forecasts
  6.2.1 By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2022
  6.2.2 By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2023-2028
  6.2.3 By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
  6.3.2 US Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.3.3 Canada Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.3.4 Mexico Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
  6.4.2 Germany Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.4.3 France Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.4.4 U.K. Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.4.5 Italy Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.4.6 Russia Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.4.7 Nordic Countries Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.4.8 Benelux Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
  6.5.2 China Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.5.3 Japan Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.5.4 South Korea Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.5.5 Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.5.6 India Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
  6.6.2 Brazil Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.6.3 Argentina Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
  6.7.2 Turkey Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.7.3 Israel Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.7.4 Saudi Arabia Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
  6.7.5 UAE Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.1.4 Merck Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Teva Pharmaceutical
  7.2.1 Teva Pharmaceutical Corporate Summary
  7.2.2 Teva Pharmaceutical Business Overview
  7.2.3 Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.2.4 Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.2.5 Teva Pharmaceutical Key News
7.3 3M
  7.3.1 3M Corporate Summary
  7.3.2 3M Business Overview
  7.3.3 3M Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.3.4 3M Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.3.5 3M Key News
7.4 Astrazeneca
  7.4.1 Astrazeneca Corporate Summary
  7.4.2 Astrazeneca Business Overview
  7.4.3 Astrazeneca Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.4.4 Astrazeneca Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.4.5 Astrazeneca Key News
7.5 Boehringer Ingelheim
  7.5.1 Boehringer Ingelheim Corporate Summary
  7.5.2 Boehringer Ingelheim Business Overview
  7.5.3 Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.5.4 Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.5.5 Boehringer Ingelheim Key News
7.6 Cipla
  7.6.1 Cipla Corporate Summary
  7.6.2 Cipla Business Overview
  7.6.3 Cipla Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.6.4 Cipla Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.6.5 Cipla Key News
7.7 Glaxosmithkline
  7.7.1 Glaxosmithkline Corporate Summary
  7.7.2 Glaxosmithkline Business Overview
  7.7.3 Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.7.4 Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.7.5 Glaxosmithkline Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.8.4 Novartis Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Omron Corporation
  7.9.1 Omron Corporation Corporate Summary
  7.9.2 Omron Corporation Business Overview
  7.9.3 Omron Corporation Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.9.4 Omron Corporation Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.9.5 Omron Corporation Key News
7.10 Sunovion Pharmaceuticals
  7.10.1 Sunovion Pharmaceuticals Corporate Summary
  7.10.2 Sunovion Pharmaceuticals Business Overview
  7.10.3 Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Major Product Offerings
  7.10.4 Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
  7.10.5 Sunovion Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pulmonary/ Respiratory Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Pulmonary/ Respiratory Drug Delivery Market Drivers in Global Market
Table 3. Pulmonary/ Respiratory Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Pulmonary/ Respiratory Drug Delivery in Global Market
Table 5. Top Pulmonary/ Respiratory Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pulmonary/ Respiratory Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pulmonary/ Respiratory Drug Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pulmonary/ Respiratory Drug Delivery Product Type
Table 9. List of Global Tier 1 Pulmonary/ Respiratory Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary/ Respiratory Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pulmonary/ Respiratory Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pulmonary/ Respiratory Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pulmonary/ Respiratory Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pulmonary/ Respiratory Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 32. Merck Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceutical Corporate Summary
Table 34. Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 35. Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 36. 3M Corporate Summary
Table 37. 3M Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 38. 3M Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 39. Astrazeneca Corporate Summary
Table 40. Astrazeneca Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 41. Astrazeneca Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 42. Boehringer Ingelheim Corporate Summary
Table 43. Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 44. Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 45. Cipla Corporate Summary
Table 46. Cipla Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 47. Cipla Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Glaxosmithkline Corporate Summary
Table 49. Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 50. Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 53. Novartis Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 54. Omron Corporation Corporate Summary
Table 55. Omron Corporation Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 56. Omron Corporation Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 57. Sunovion Pharmaceuticals Corporate Summary
Table 58. Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Product Offerings
Table 59. Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pulmonary/ Respiratory Drug Delivery Segment by Type in 2021
Figure 2. Pulmonary/ Respiratory Drug Delivery Segment by Application in 2021
Figure 3. Global Pulmonary/ Respiratory Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pulmonary/ Respiratory Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pulmonary/ Respiratory Drug Delivery Revenue in 2021
Figure 8. By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
Figure 12. US Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
Figure 24. China Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. 3M Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astrazeneca Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cipla Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Omron Corporation Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)